Muscarinic M1 receptor agonists and M2 receptor antagonists as therapeutic targets in Alzheimer’s disease

By Sheardown Malcolm J  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 863-870

Informa Healthcare

Access to resources Recommend Favorite

Muscarinic Receptor Agonists and Antagonists in the Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3353-3361

Bentham Science Publishers

Access to resources Recommend Favorite

Muscarinic agonists for the treatment of Alzheimer's disease: progress and perspectives

By Fisher A.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 10, 1997-10 ,pp. : 1395-1412

Informa Healthcare

Access to resources Recommend Favorite

Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M 1 receptors

By Messer W.S.   Rajeswaran W.G.   Cao Y.   Zhang H.-J.   El-Assadi A.A.   Dockery C.   Liske J.   O'Brien J.   Williams F.E.   Huang X.-P.   Wroblewski M.E.   Nagy P.I.   Peseckis S.M.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 2, 2000-03 ,pp. : 135-140

Elsevier

Access to resources Recommend Favorite

Cholinergic Agonists and the Treatment of Alzheimer's Disease

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 4, 2002-01 ,pp. : 353-358

Bentham Science Publishers

Access to resources Recommend Favorite